ANAVEX LIFE SCIENCES CORP (AVXL) Stock News

USA - NASDAQ:AVXL - US0327973006 - Common Stock

8.1 USD

-0.39 (-4.59%)

Last: 10/28/2025, 8:00:01 PM

8.0866 USD

-0.01 (-0.17%)

After Hours: 10/28/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

AVXL Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: Stocktwits

Anavex Life Sciences Stock Sparks Retail Banter On Hopes Of EMA Conditional Nod For Alzheimer's Drug, Big Pharma Tie-Up

19 days ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’

a month ago - By: Stocktwits - Mentions: EAOR ITOT

News Image

Anavex Life Sciences Stock Just Shot Up 7% Today – Here’s An Important Update

a month ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program

2 months ago - By: Stocktwits - Mentions: EAOR VTWG

News Image

Anavex Life Sciences Stock Rises After Experimental Alzheimer’s Drug Slows Cognitive Decline In Study

a month ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

a month ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer’s Disease Trial

2 months ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer’s Disease Trial

2 months ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025

2 months ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences Reports New Publication in Medical Journal Highlighting the Established Precise Autophagy Mechanism with Blarcamesine

3 months ago - By: Benzinga

What to Expect from Anavex Life Sciences's Earnings

4 months ago - By: Stocktwits

News Image

Anavex Life Sciences Stock Falls After Hours On $300M Raise Plan; Retail Traders Think It’s A ‘Smart’ Move

2 months ago - By: Benzinga

Anavex Life Pre-Treatment Prevented Cognitive Impairment In Animal Model of Alzheimer's Disease, New Publication Shows

2 months ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer’s Disease

3 months ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences Reports Fiscal 2025 Third Quarter Financial Results and Provides Business Update

3 months ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Financial Results on Tuesday, August 12, 2025

3 months ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences Announces Positive Precision Medicine Results from up to 4-Years of Oral Blarcamesine Treatment in Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease

4 months ago - By: Stocktwits - Mentions: BULL SBET BBAI OSCR

Top 5 Trending Stocks On Stocktwits Today: Webull, SharpLink, Anavex Life Sciences, BigBear.ai, And Oscar Health

6 months ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences to Participate at Upcoming Healthcare Conferences

6 months ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update

6 months ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences to Announce Fiscal 2025 Second Quarter Financial Results on Tuesday, May 13, 2025

6 months ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

6 months ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences to Participate in The Citizens Life Sciences Conference